Publication

Article

BioPharm International

BioPharm International-09-15-2014
Volume2014 eBook
Issue 3

Ensuring Sound Bioanalytical Methods Transfer

A Q&A on bioanalytical method integrity with Roger Hayes of MPI Research.

 

A Q&A on bioanalytical method integrity with Roger Hayes of MPI Research.

 

Read this article

from BioPharm International’s 2014 Outsourcing Strategies eBook.

View other articles in the 

2014 Outsourcing Strategies eBook

.

 

 

 

 

 

Articles in this issue
BPsupp0914_Pricing_200.jpg
Biopharma Contract Manufacturing Prices Go Up—and Down
BPsupp0914_MPI_TechTransfer_200.jpg
Ensuring Sound Bioanalytical Methods Transfer
BPsupp0914_Feature_CMO_200.jpg
CMOs Gear Up for Biologics Manufacturing Challenges
BPsupp0914_PPD_200.jpg
Weighing Clinical Trial Outsourcing Options
BPsupp0914_JLL_RealEstate_200.jpg
Global Biopharma Industry Shifts Echoed in Real Estate and Facilities Clusters
BPsupp0914_LangerR2_200.jpg
Outsourcing Trends in Biopharmaceutical Manufacturing

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Related Content
Binary code and lock shape on pixellated screen | Image Credit: © JohanSwanepoel - © JohanSwanepoel - stock.adobe.com
September 13th 2025

PDA 2025: Data Governance and AI's Impact on Drug Manufacturing

Feliza Mirasol
Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically
September 13th 2025

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
Ribosome translating mRNA into a polypeptide chain | Image Credit: © Juan Gärtner - © Juan Gärtner - stock.adobe.com
September 13th 2025

Quotient Sciences and CPI Target Faster RNA-Based Drug Development

Feliza Mirasol
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
September 13th 2025

What the Aptamer-Invizius H-Guard Immune Modulation Collab Means for Biopharma

Feliza Mirasol
Loading a DNA tube into a PCR (polymerase chain reaction) thermocycler machine in a bioscience laboratory. Concept of science, laboratory and study of diseases. Coronavirus (COVID-19) treatment | Image Credit: © dhvstockphoto - © dhvstockphoto - stock.adobe.com
September 13th 2025

CGT Diagnostic Testing Partners Require Pioneering Spirit in Rapidly Evolving Landscape

Phil Robertson
small interfering RNA bound to a messenger RNA, cartoon model with semi-transparent surface. siRNAs are synthetic RNA interference tools used for inducing temporary reduction of mRNA expression. | Image Credit: © petarg - © petarg - stock.adobe.com
September 13th 2025

Hongene Expands exNA Technology Access for RNA Therapeutics Research with New Licensing Deal

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.